Dysbiosis of intestinal microbiota associated with inflammation involved in the progression of acute pancreatitis

Pancreas

Volumn 44, Issue 6, 2015, Pages 868-875

  Tan, Chaochao ^a,b   Ling, Zongxin ^c   Huang, Ying ^a   Cao, Youde ^a   Liu, Qiang ^d   Cai, Tao ^d   Yuan, Hao ^a   Liu, Changjun ^a   Li, Yunfeng ^a   Xu, Keqian ^b  

^a Hunan Provincial Second People s Hospital   (China)

^b Central South University   (China)

^c ZHEJIANG UNIVERSITY   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Abbreviations; acute pancreatitis; AP acute pancreatitis; APACHE II Acute Physiology And Chronic Health Evaluation II; BMI body mass index; DGGE denaturing gradient gel electrophoresis; ELISA enzyme linked immunosorbent assay; IL 1 interleukin 1; interleukin 6; intestinal microbiota; LAL Limulus amebocyte lysate; MAP mild acute pancreatitis; MOF multiple organ failure; PCR polymerase chain reaction; polymerase chain reaction denaturing gradient gel electrophoresis; qPCR quantitative PCR; SAP severe acute pancreatitis; SIRS systemic inflammatory syndrome; TNF tumor necrosis factor

Indexed keywords

ENDOTOXIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; BACTERIAL DNA; BIOLOGICAL MARKER; CYTOKINE;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; BIFIDOBACTERIUM; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DISEASE COURSE; DYSBIOSIS; ENTEROBACTERIACEAE; ENTEROCOCCUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES MICROFLORA; FEMALE; HUMAN; INFECTIOUS COMPLICATION; INTESTINE FLORA; LIMULUS LYSATE TEST; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; ACUTE DISEASE; BACTERIUM; BLOOD; CASE CONTROL STUDY; CHINA; CLASSIFICATION; CLINICAL TRIAL; FECES; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INTESTINE; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; MULTICENTER STUDY; PANCREATITIS; PREDICTIVE VALUE; RISK FACTOR; SEVERITY OF ILLNESS INDEX;

ACUTE DISEASE; ADULT; BACTERIA; BIOMARKERS; CASE-CONTROL STUDIES; CHINA; CYTOKINES; DENATURING GRADIENT GEL ELECTROPHORESIS; DISEASE PROGRESSION; DNA, BACTERIAL; DYSBIOSIS; ENDOTOXINS; FECES; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATION MEDIATORS; INTESTINES; MALE; MICROBIOTA; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PANCREATITIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84937856070     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0000000000000355     Document Type: Article

References (41)

1. Eckburg PB, Bik EM, Bernstein CN, Diversity of the human intestinal microbial flora. Science. 2005; 308: 1635-1638
2. Bergonzelli GE, Blum S, Brussow H, Probiotics as a treatment strategy for gastrointestinal diseases? Digestion. 2005; 72: 57-68
3. Elson CO, Cong Y,. Host-microbiota interactions in inflammatory bowel disease. Gut Microbes. 2012; 3: 332-344
4. Fujimura KE, Slusher NA, Cabana MD, Role of the gut microbiota in defining human health. Expert Rev Anti Infect Ther. 2010; 8: 435-454
5. Li M, Wang B, Zhang M, Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A. 2008; 105: 2117-2122
6. Emami CN, Petrosyan M, Giuliani S, Role of the host defense system and intestinal microbial flora in the pathogenesis of necrotizing enterocolitis. Surg Infect (Larchmt). 2009; 10: 407-417
7. Wen L, Ley RE, Volchkov PY, Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature. 2008; 455: 1109-1113
8. Lupp C, Robertson ML, Wickham ME, Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe. 2007; 2: 204
9. Bumbasirevic V, Radenkovic D, Jankovic Z, Severe acute pancreatitis: overall and early versus late mortality in intensive care units. Pancreas. 2009; 38: 122-125
10. Petrov MS, Shanbhag S, Chakraborty M, Organ failure and infection of pancreatic necrosis as determinants of mortality in patients with acute pancreatitis. Gastroenterology. 2010; 139: 813-820
11. Beger HG, Rau B, Isenmann R,. Natural history of necrotizing pancreatitis. Pancreatology. 2003; 3: 93-101
12. Van Felius ID, Akkermans LM, Bosscha K, Interdigestive small bowel motility and duodenal bacterial overgrowth in experimental acute pancreatitis. Neurogastroenterol Motil. 2003; 15: 267-276
13. Lutgendorff F, Nijmeijer RM, Sandstrom PA, Probiotics prevent intestinal barrier dysfunction in acute pancreatitis in rats via induction of ileal mucosal glutathione biosynthesis. PLoS One. 2009; 4: e4512
14. Gerritsen J, Timmerman HM, Fuentes S, Correlation between protection against sepsis by probiotic therapy and stimulation of a novel bacterial phylotype. Appl Environ Microbiol. 2011; 77: 7749-7756
15. Capurso G, Zerboni G, Signoretti M, Role of the gut barrier in acute pancreatitis. J Clin Gastroenterol. 2012; 46 (suppl): S46-S51
16. Rychter JW, van Minnen LP, Verheem A, Pretreatment but not treatment with probiotics abolishes mouse intestinal barrier dysfunction in acute pancreatitis. Surgery. 2009; 145: 157-167
17. Ammori BJ,. Role of the gut in the course of severe acute pancreatitis. Pancreas. 2003; 26: 122-129
18. van Baal MC, Kohout P, Besselink MG, Probiotic treatment with Probioflora in patients with predicted severe acute pancreatitis without organ failure. Pancreatology. 2012; 12: 458-462
19. Sharma B, Srivastava S, Singh N, Role of probiotics on gut permeability and endotoxemia in patients with acute pancreatitis: a double-blind randomized controlled trial. J Clin Gastroenterol. 2011; 45: 442-448
20. Besselink MG, van Santvoort HC, Buskens E, Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2008; 371: 651-659
21. Malmstrom ML, Hansen MB, Andersen AM, Cytokines and organ failure in acute pancreatitis: inflammatory response in acute pancreatitis. Pancreas. 2012; 41: 271-277
22. Kylanpaa ML, Repo H, Puolakkainen PA,. Inflammation and immunosuppression in severe acute pancreatitis. World J Gastroenterol. 2010; 16: 2867-2872
23. Elfar M, Gaber LW, Sabek O, The inflammatory cascade in acute pancreatitis: relevance to clinical disease. Surg Clin North Am. 2007; 87: 1325-1340. vii
24. Kawamoto S, Tran TH, Maruya M, The inhibitory receptor PD-1 regulates IgA selection and bacterial composition in the gut. Science. 2012; 336: 485-489
25. Young JA, He TH, Reizis B, Commensal microbiota are required for systemic inflammation triggered by necrotic dendritic cells. Cell Rep. 2013; 3: 1932-1944
26. Hill DA, Siracusa MC, Abt MC, Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation. Nat Med. 2012; 18: 538-546
27. Bradley EL 3rd, A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg. 1993; 128: 586-590
28. Ling Z, Kong J, Jia P, Analysis of oral microbiota in children with dental caries by PCR-DGGE and barcoded pyrosequencing. Microb Ecol. 2010; 60: 677-690
29. Ling Z, Kong J, Liu F, Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis. BMC Genomics. 2010; 11: 488
30. Muyzer G, de Waal EC, Uitterlinden AG,. Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-Amplified genes coding for 16S rRNA. Appl Environ Microbiol. 1993; 59: 695-700
31. Bartosch S, Fite A, Macfarlane GT, Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-Time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol. 2004; 70: 3575-3581
32. Chen Y, Yang F, Lu H, Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology. 2011; 54: 562-572
33. Wu ZW, Ling ZX, Lu HF, Changes of gut bacteria and immune parameters in liver transplant recipients. Hepatobiliary Pancreat Dis Int. 2012; 11: 40-50
34. Besselink MG, van Santvoort HC, Boermeester MA, Timing and impact of infections in acute pancreatitis. Br J Surg. 2009; 96: 267-273
35. Bauer TM, Schwacha H, Steinbruckner B, Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia. Am J Gastroenterol. 2002; 97: 2364-2370
36. Manichanh C, Rigottier-Gois L, Bonnaud E, Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut. 2006; 55: 205-211
37. Zeng J, Li YQ, Zuo XL, Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2008; 28: 994-1002
38. Granger J, Remick D,. Acute pancreatitis: models, markers, and mediators. Shock. 2005; 24 (suppl 1): 45-51
39. Gunjaca I, Zunic J, Gunjaca M, Circulating cytokine levels in acute pancreatitis-model of SIRS/CARS can help in the clinical assessment of disease severity. Inflammation. 2012; 35: 758-763
40. Tsuji Y, Watanabe T, Kudo M, Sensing of commensal organisms by the intracellular sensor NOD1 mediates experimental pancreatitis. Immunity. 2012; 37: 326-338
41. Qin HL, Zheng JJ, Tong DN, Effect of Lactobacillus plantarum enteral feeding on the gut permeability and septic complications in the patients with acute pancreatitis. Eur J Clin Nutr. 2008; 62: 923-930